Literature DB >> 10722559

Left ventricular opacification during selective intracoronary injection of echocardiographic contrast in patients with hypertrophic cardiomyopathy.

P M Elliott1, S J Brecker, W J McKenna.   

Abstract

Percutaneous alcohol ablation of the interventricular septum via the first septal perforator branch of the left anterior descending artery can successfully treat dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Increasingly, echocardiographic contrast agents are used before alcohol injection to identify the perfusion bed of the septal perforator vessels. This study describes the unexpected opacification of the left ventricular cavity in three of five consecutive patients following selective injection of the first septal perforator with Optison. This case study demonstrates that direct communication between the first septal perforator vessel and the left ventricle is common, an observation that may have considerable relevance to the technique of alcohol septal reduction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722559      PMCID: PMC1729378          DOI: 10.1136/heart.83.4.e7

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.

Authors:  C Knight; A S Kurbaan; H Seggewiss; M Henein; M Gunning; D Harrington; D Fassbender; U Gleichmann; U Sigwart
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

2.  THEBESIAN DRAINAGE IN THE LEFT HEART OF THE DOG.

Authors:  T W MOIR; T E DRISCOL; R W ECKSTEIN
Journal:  Circ Res       Date:  1964-03       Impact factor: 17.367

3.  Coronary artery-left ventricular fistula with apical hypertrophic cardiomyopathy.

Authors:  C K Wong; C P Lau; C H Cheng
Journal:  Eur Heart J       Date:  1991-02       Impact factor: 29.983

4.  Myocardial contrast echocardiography can depict thebesian vein outflow in humans.

Authors:  J H Cornel; F J Ten Cate; P W Serruys
Journal:  Am Heart J       Date:  1992-05       Impact factor: 4.749

5.  Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.

Authors:  S F Nagueh; N M Lakkis; Z X He; K J Middleton; D Killip; W A Zoghbi; M A Quiñones; R Roberts; M S Verani; N S Kleiman; W H Spencer
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

6.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.

Authors:  H Seggewiss; U Gleichmann; L Faber; D Fassbender; H K Schmidt; S Strick
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

7.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Authors:  U Sigwart
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.